There was elevated nuclear expression of IRS4 in liver cancer and treatment of HEPG2 cell, a liver cancer cell line with IGF-1 and EGF-induced nuclear translocation of IRS4, stimulating cell proliferation by a β-catenin/Rb/cyclin D mechanism [74]. This evidence concerns the gene EGF and liver cancer.